ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

ClinicalTrials.gov ID: NCT01179048

Public ClinicalTrials.gov record NCT01179048. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events

Study identification

NCT ID
NCT01179048
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
9,341 participants

Conditions and interventions

Interventions

  • liraglutide Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2010
Primary completion
Dec 16, 2015
Completion
Dec 16, 2015
Last update posted
Jul 16, 2019

2010 – 2015

United States locations

U.S. sites
125
U.S. states
33
U.S. cities
109
Facility City State ZIP Site status
Novo Nordisk Investigational Site Alabaster Alabama 35007
Novo Nordisk Investigational Site Birmingham Alabama 35209
Novo Nordisk Investigational Site Birmingham Alabama 35294
Novo Nordisk Investigational Site Huntsville Alabama 35801
Novo Nordisk Investigational Site Mobile Alabama 36608
Novo Nordisk Investigational Site Tempe Arizona 85283
Novo Nordisk Investigational Site Little Rock Arkansas 72205-5446
Novo Nordisk Investigational Site Little Rock Arkansas 72205
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Cerritos California 90703-2115
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fresno California 93721-1443
Novo Nordisk Investigational Site Los Angeles California 90017-4006
Novo Nordisk Investigational Site Los Banos California 93635
Novo Nordisk Investigational Site Mission Hills California 91345
Novo Nordisk Investigational Site Montclair California 91763
Novo Nordisk Investigational Site San Diego California 92111
Novo Nordisk Investigational Site Tustin California 92780
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Watsonville California 95076
Novo Nordisk Investigational Site Aurora Colorado 80045-7402
Novo Nordisk Investigational Site Denver Colorado 80220
Novo Nordisk Investigational Site Newark Delaware 19713
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Clearwater Florida 33756
Novo Nordisk Investigational Site DeLand Florida 32724
Novo Nordisk Investigational Site Fort Lauderdale Florida 33316
Novo Nordisk Investigational Site Kissimmee Florida 34744
Novo Nordisk Investigational Site Miami Florida 33136
Novo Nordisk Investigational Site Orlando Florida 32804
Novo Nordisk Investigational Site St. Petersburg Florida 33711
Novo Nordisk Investigational Site Tampa Florida 33624
Novo Nordisk Investigational Site West Palm Beach Florida 33409
Novo Nordisk Investigational Site Lawrenceville Georgia 30046
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Chicago Illinois 60612
Novo Nordisk Investigational Site Chicago Illinois 60654
Novo Nordisk Investigational Site Crystal Lake Illinois 60012
Novo Nordisk Investigational Site Indianapolis Indiana 46260-1992
Novo Nordisk Investigational Site Michigan City Indiana 46360
Novo Nordisk Investigational Site West Des Moines Iowa 50265
Novo Nordisk Investigational Site Lexington Kentucky 40502
Novo Nordisk Investigational Site Louisville Kentucky 40202
Novo Nordisk Investigational Site Louisville Kentucky 40206
Novo Nordisk Investigational Site Metairie Louisiana 70006-2930
Novo Nordisk Investigational Site Monroe Louisiana 71203
Novo Nordisk Investigational Site Natchitoches Louisiana 71457-5881
Novo Nordisk Investigational Site New Orleans Louisiana 70112
Novo Nordisk Investigational Site Baltimore Maryland 21204
Novo Nordisk Investigational Site Baltimore Maryland 21218-2829
Novo Nordisk Investigational Site Bloomfield Hills Michigan 48302
Novo Nordisk Investigational Site Dearborn Michigan 48124
Novo Nordisk Investigational Site Interlochen Michigan 49643
Novo Nordisk Investigational Site Troy Michigan 48085-5524
Novo Nordisk Investigational Site Minneapolis Minnesota 55416
Novo Nordisk Investigational Site Springfield Missouri 65807
Novo Nordisk Investigational Site St Louis Missouri 63108
Novo Nordisk Investigational Site Great Falls Montana 59405
Novo Nordisk Investigational Site Omaha Nebraska 68105
Novo Nordisk Investigational Site Lebanon New Hampshire 03756
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Mine Hill New Jersey 07803
Novo Nordisk Investigational Site Neptune City New Jersey 07753-4859
Novo Nordisk Investigational Site Albany New York 12208
Novo Nordisk Investigational Site Buffalo New York 14221-7091
Novo Nordisk Investigational Site New York New York 10032
Novo Nordisk Investigational Site New York New York 10036
Novo Nordisk Investigational Site New York New York 10065
Novo Nordisk Investigational Site Smithtown New York 11787
Novo Nordisk Investigational Site Syracuse New York 13210
Novo Nordisk Investigational Site Westfield New York 14787
Novo Nordisk Investigational Site Asheville North Carolina 28801
Novo Nordisk Investigational Site Burlington North Carolina 27215
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517
Novo Nordisk Investigational Site Greensboro North Carolina 27401
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Monroe North Carolina 28110
Novo Nordisk Investigational Site Mooresville North Carolina 28117
Novo Nordisk Investigational Site Morehead City North Carolina 28557
Novo Nordisk Investigational Site Whiteville North Carolina 28472
Novo Nordisk Investigational Site Cadiz Ohio 43907
Novo Nordisk Investigational Site Cincinnati Ohio 45219
Novo Nordisk Investigational Site Cincinnati Ohio 45220-2213
Novo Nordisk Investigational Site Cleveland Ohio 44106
Novo Nordisk Investigational Site Marion Ohio 43302
Novo Nordisk Investigational Site Middleburg Heights Ohio 44310
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104
Novo Nordisk Investigational Site Altoona Pennsylvania 16602
Novo Nordisk Investigational Site Beaver Pennsylvania 15009-1957
Novo Nordisk Investigational Site Hatfield Pennsylvania 19440
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15243
Novo Nordisk Investigational Site Uniontown Pennsylvania 15401
Novo Nordisk Investigational Site Charleston South Carolina 29455
Novo Nordisk Investigational Site Columbia South Carolina 29203
Novo Nordisk Investigational Site Greenville South Carolina 29607
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Murrells Inlet South Carolina 29576
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572
Novo Nordisk Investigational Site Bartlett Tennessee 38133
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Memphis Tennessee 38163
Novo Nordisk Investigational Site Nashville Tennessee 37212
Novo Nordisk Investigational Site Arlington Texas 76014
Novo Nordisk Investigational Site Corpus Christi Texas 78404
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390
Novo Nordisk Investigational Site Houston Texas 77070
Novo Nordisk Investigational Site Houston Texas 77095
Novo Nordisk Investigational Site Longview Texas 75605
Novo Nordisk Investigational Site Lubbock Texas 79423
Novo Nordisk Investigational Site Odessa Texas 79761
Novo Nordisk Investigational Site San Antonio Texas 78228-3419
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Schertz Texas 78154
Novo Nordisk Investigational Site Tomball Texas 77375
Novo Nordisk Investigational Site Salt Lake City Utah 84102
Novo Nordisk Investigational Site South Burlington Vermont 05403
Novo Nordisk Investigational Site Spokane Washington 99210
Novo Nordisk Investigational Site Madison Wisconsin 53717

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 303 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01179048, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 16, 2019 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01179048 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →